Search for Clinical Trial Results

Sponsored By

Siderosis - 26 Studies Found

Status Study
Completed Study Name: Evaluation of the Safety, Tolerability, Pharmacokinetics (PK) and Effects on Liver Iron Concentration of ICL670 Relative to Deferoxamine(DFO).
Condition: Sickle Cell Disease
Date: 2010-03-15
Interventions: Drug: ICL670 Daily doses of ICL670 were taken orally 30 minutes before breakfast. The doses range from 5
Completed Study Name: A Protocol to Allow Treatment With ICL670 for Patients With or at Risk of Life-threatening Complications of Transfusional Iron Overload Who Are Unable to Tolerate Other Iron Chelators Because of Documented Severe Toxicity
Condition: Transfusional Iron Overload
Date: 2010-01-05
Interventions: Drug: ICL670
Completed Study Name: T2* in Transfusion Dependant Anemia, MI, LVF, Normal Patients
Condition: Thalassemia
Date: 2007-08-23
Completed Study Name: Amlodipine for Myocardial Iron in Thalassemia
Condition: Thalassemia
Date: 2014-02-17
Interventions:
  • Drug: Standard Chelation This

Completed Study Name: A Longitudinal Study of Effect of Copaxone in RRMS Over 24 Months
Condition: Multiple Sclerosis
Date: 2012-09-26
Interventions: Other: MRI All subjects will undergo a MRI.
Completed Study Name: Rebif Advanced Magnetic Resonance Imaging (MRI) and Immunology Pilot Trial
Condition: Multiple Sclerosis
Date: 2010-03-10
Interventions: Drug: Rebif 44 mcg tiw
<<< Previous